MP
COCH icon

Mangrove Partners’s Envoy Medical COCH Stock Holding History

Mangrove Partners’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-193,252
Closed -$1.88M – 461
2021
Q4 		$1.88M Sell
193,252
-6,746
-3% -$65.8K 0.11% 369
2021
Q3 		$1.94M Hold
199,998
– – 0.17% 235
2021
Q2 		$1.95M Buy
+199,998
New +$1.94M 0.2% 163

Other funds holding COCH

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Mangrove Partners's COCH Position: Q1 2022 in Review

Mangrove Partners sold out of Envoy Medical (COCH) in Q1 2022, closing a stake of 193,252 shares — an estimated $1.88M sold.

Mangrove Partners first reported a position in COCH in Q2 2021 and held it in 3 quarters. The position peaked at $1.95M in Q2 2021. 84 funds tracked by Wall St. Rank hold COCH as of Q1 2022.

  • Mangrove Partners reported no remaining Envoy Medical position as of Q1 2022 after selling out during the quarter.
  • Mangrove Partners sold 193,252 Envoy Medical shares in Q1 2022, an estimated $1.88M.
  • Mangrove Partners first reported a position in Envoy Medical in Q2 2021 and held it in 3 quarters.
  • Mangrove Partners's Envoy Medical position peaked at $1.95M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.